Upgrade to SI Premium - Free Trial

BofA Securities Moves GlaxoSmithKline (GSK) at Underperform

December 5, 2022 5:47 AM
(Updated - December 5, 2022 5:55 AM EST)

BofA Securities analyst Graham Perry downgrades GlaxoSmithKline (NYSE: GSK) Underperform rating ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Downgrades

Next Articles